News summarySeeking AlphaOct 30, 2026, 03:46 PM
Axsome Therapeutics Q3 2026 Earnings Preview
Axsome Therapeutics is scheduled to report third-quarter results before market open on Monday, November 2. [[fact:fact-9pdwxe7uy]] The consensus estimate is a loss of $0.64 per share, an improvement of 31.9% year over year. [[fact:fact-tinie3g9x]] The consensus revenue estimate is $249.19 million, up 45.7% year over year. [[fact:fact-unh51j6sy]]